These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Supragastric belching in Japan: lower prevalence and relevance for management of gastroesophageal reflux disease compared to United Kingdom. Sawada A; Itami H; Nakagawa K; Hirano S; Kitamura H; Nakata R; Takashima S; Abe Y; Saito M; Yazaki E; Kawamura O; Tanaka F; Takeuchi T; Koike T; Masamune A; Fujiwara Y; Higuchi K; Sifrim D J Gastroenterol; 2020 Nov; 55(11):1046-1053. PubMed ID: 32839926 [TBL] [Abstract][Full Text] [Related]
4. Identification of Different Phenotypes of Esophageal Reflux Hypersensitivity and Implications for Treatment. Sawada A; Guzman M; Nikaki K; Sonmez S; Yazaki E; Aziz Q; Woodland P; Rogers B; Gyawali CP; Sifrim D Clin Gastroenterol Hepatol; 2021 Apr; 19(4):690-698.e2. PubMed ID: 32272249 [TBL] [Abstract][Full Text] [Related]
5. Belching Disorders and Rumination Syndrome: A Literature Review. Sawada A; Fujiwara Y Digestion; 2024; 105(1):18-25. PubMed ID: 37844547 [TBL] [Abstract][Full Text] [Related]
6. The influence of supragastric belching severity on esophageal acid exposure and motility. Sergeev I; Velosa M; Mardare R; Yazaki E; Sifrim D Neurogastroenterol Motil; 2023 Apr; 35(4):e14520. PubMed ID: 36537295 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of symptomatic belching in patients with belching disorder and patients who exhibit gastroesophageal reflux disease with belching. Jeong SO; Lee JS; Lee TH; Hong SJ; Cho YK; Park J; Jeon SR; Kim HG; Kim JO J Neurogastroenterol Motil; 2021 Apr; 27(2):231-239. PubMed ID: 33424014 [TBL] [Abstract][Full Text] [Related]
8. Impact of laparoscopic antireflux surgery on belching in pediatric GERD patients. Rinsma NF; Mauritz FA; van Heurn LW; Sloots CE; Siersema PD; Houwen RH; van der Zee DC; Masclee AA; Conchillo JM; Van Herwaarden-Lindeboom MY Neurogastroenterol Motil; 2016 Oct; 28(10):1525-32. PubMed ID: 27151185 [TBL] [Abstract][Full Text] [Related]
9. Postprandial High-Resolution Impedance Manometry Identifies Mechanisms of Nonresponse to Proton Pump Inhibitors. Yadlapati R; Tye M; Roman S; Kahrilas PJ; Ritter K; Pandolfino JE Clin Gastroenterol Hepatol; 2018 Feb; 16(2):211-218.e1. PubMed ID: 28911949 [TBL] [Abstract][Full Text] [Related]
10. ARE THE PERSISTENT SYMPTOMS TO PROTON PUMP INHIBITOR THERAPY DUE TO REFRACTORY GASTROESOPHAGEAL REFLUX DISEASE OR TO OTHER DISORDERS? Azzam RS Arq Gastroenterol; 2018 Nov; 55Suppl 1(Suppl 1):85-91. PubMed ID: 30304291 [TBL] [Abstract][Full Text] [Related]
11. Supragastric Belching: Prevalence and Association With Gastroesophageal Reflux Disease and Esophageal Hypomotility. Koukias N; Woodland P; Yazaki E; Sifrim D J Neurogastroenterol Motil; 2015 Jul; 21(3):398-403. PubMed ID: 26130635 [TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal Reflux Characteristics in Supragastric Belching Patients With Positive Versus Negative pH Monitoring: An Evidence of Secondary Gastroesophageal Reflux Disease From Excessive Belching. Keeratichananont S; Patcharatrakul T; Gonlachanvit S J Neurogastroenterol Motil; 2023 Jul; 29(3):343-351. PubMed ID: 37417261 [TBL] [Abstract][Full Text] [Related]
13. Belching: dyspepsia or gastroesophageal reflux disease? Lin M; Triadafilopoulos G Am J Gastroenterol; 2003 Oct; 98(10):2139-45. PubMed ID: 14572558 [TBL] [Abstract][Full Text] [Related]
14. Does severe and chronic esophageal distension by air (observed in SGB and GB) affect the esophageal mucosa integrity (MNBI). Voulgaris T; Hoshino S; Sifrim D; Yazaki E Neurogastroenterol Motil; 2024 Mar; 36(3):e14731. PubMed ID: 38148498 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of behavioral disorders in patients with vonoprazan-refractory reflux symptoms. Hoshikawa Y; Hoshino S; Kawami N; Iwakiri K J Gastroenterol; 2021 Feb; 56(2):117-124. PubMed ID: 33247348 [TBL] [Abstract][Full Text] [Related]
16. Supragastric belching: Pathogenesis, diagnostic issues and treatment. Popa SL; Surdea-Blaga T; David L; Stanculete MF; Picos A; Dumitrascu DL; Chiarioni G; Ismaiel A; Dumitrascu DI Saudi J Gastroenterol; 2022; 28(3):168-174. PubMed ID: 35562166 [TBL] [Abstract][Full Text] [Related]
17. Treatment of supragastric belching with cognitive behavioral therapy improves quality of life and reduces acid gastroesophageal reflux. Glasinovic E; Wynter E; Arguero J; Ooi J; Nakagawa K; Yazaki E; Hajek P; Psych CC; Woodland P; Sifrim D Am J Gastroenterol; 2018 Apr; 113(4):539-547. PubMed ID: 29460918 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non-erosive reflux disease. Ribolsi M; Cicala M; Zentilin P; Neri M; Mauro A; Efthymakis K; Petitti T; Savarino V; Penagini R Aliment Pharmacol Ther; 2018 Nov; 48(10):1074-1081. PubMed ID: 30294924 [TBL] [Abstract][Full Text] [Related]
19. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo Schey R; Alla SP; Midani D; Parkman HP Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467 [TBL] [Abstract][Full Text] [Related]